We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+13.64%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$894M
AUM Growth
-$17.6M
Cap. Flow
-$98M
Cap. Flow %
-10.96%
Top 10 Hldgs %
38.65%
Holding
76
New
8
Increased
23
Reduced
28
Closed
9

Top Buys

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$30.1M
2
IMMU
Immunomedics Inc
IMMU
+$14M
3
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$11.4M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$9.85M
5
ARRY
Array Biopharma Inc
ARRY
+$8.51M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$23.5M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
+$17.6M
3
TSRO
TESARO, Inc.
TSRO
+$12.9M
4
EW icon
Edwards Lifesciences
EW
+$12.5M
5
ABT icon
Abbott
ABT
+$12.1M

Sector Composition

Rank Sector Weight
1 Healthcare 84.98%
2 Technology 0.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLRN
26
DELISTED
Acceleron Pharma
XLRN
$14.9M 1.66%
306,626
+82,400
+37% +$3M
PRAH
27
DELISTED
PRA Health Sciences, Inc.
PRAH
$13.9M 1.55%
148,560
-2,000
-1% -$172K
ADMS
28
DELISTED
Adamas Pharmaceuticals
ADMS
$13.8M 1.55%
535,520
+184,200
+52% +$5.1M
MDT icon
29
Medtronic
MDT
$107B
$12.7M 1.41%
147,800
-76,800
-34% -$6.41M
IRTC icon
30
iRhythm Holdings
IRTC
$3.59B
$11.7M 1.31%
144,700
-12,900
-8% -$902K
BMY icon
31
Bristol-Myers Squibb
BMY
$127B
$10.8M 1.2%
194,389
+41,189
+27% +$2.22M
MDGL icon
32
Madrigal Pharmaceuticals
MDGL
$12.6B
$10.7M 1.19%
38,149
-12,500
-25% -$2.19M
LLY icon
33
Eli Lilly
LLY
$1.07T
$10.5M 1.17%
122,600
-59,500
-33% -$4.89M
GBT
34
DELISTED
Global Blood Therapeutics, Inc.
GBT
$10.4M 1.17%
230,694
+43,700
+23% +$1.99M
EVH icon
35
Evolent Health
EVH
$475M
$9.87M 1.1%
468,882
+45,400
+11% +$859K
ESPR
36
DELISTED
Esperion Therapeutics
ESPR
$8.25M 0.92%
210,468
+78,000
+59% +$3.94M
OBSV
37
DELISTED
ObsEva SA Ordinary Shares
OBSV
$8.15M 0.91%
538,151
+248,644
+86% +$3.3M
PODD icon
38
Insulet
PODD
$11.3B
$8.1M 0.91%
94,509
– –
WMGI
39
DELISTED
Wright Medical Group Inc
WMGI
$7.99M 0.89%
307,672
– –
HRC
40
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$7.91M 0.88%
90,600
+2,400
+3% +$213K
CI icon
41
Cigna
CI
$76.6B
$7.81M 0.87%
45,938
-13,299
-22% -$2.3M
NVRO
42
DELISTED
NEVRO CORP.
NVRO
$6.71M 0.75%
84,000
-13,400
-14% -$1.11M
VRAY
43
DELISTED
ViewRay, Inc.
VRAY
$6.68M 0.75%
966,064
-173,799
-15% -$1.26M
BSX icon
44
Boston Scientific
BSX
$65.8B
$6.21M 0.69%
+189,900
New +$5.73M
ALBO
45
DELISTED
Albireo Pharma Inc
ALBO
$6.13M 0.69%
172,803
– –
EW icon
46
Edwards Lifesciences
EW
$47.6B
$5.95M 0.67%
122,580
-267,297
-69% -$12.5M
SAGE
47
DELISTED
Sage Therapeutics
SAGE
$5.81M 0.65%
37,100
+4,500
+14% +$706K
ABT icon
48
Abbott
ABT
$180B
$5.73M 0.64%
93,899
-200,400
-68% -$12.1M
INCY icon
49
Incyte
INCY
$23.5B
$5.31M 0.59%
79,245
– –
EVLO
50
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$5.16M 0.58%
+21,875
New +$6.38M
1
2
3 4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q2 2018 Portfolio in Review

As of Q2 2018, Sectoral Asset Management held 76 positions worth $894M, down 1.9% from $912M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Sectoral Asset Management withdrew a net $98M in Q2 2018, closing 9 positions and reducing 28 holdings. Its most notable exit was Acadia Pharmaceuticals, an estimated $17.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 91% a quarter earlier, followed by Technology.

Against the trend, Sectoral Asset Management opened a new position in Alnylam Pharmaceuticals worth $29.9M.

  • Sectoral Asset Management's largest Q2 2018 buy was Alnylam Pharmaceuticals: 303,700 shares worth $29.9M.
  • Sectoral Asset Management added most to Portola Pharmaceuticals, Inc. in Q2 2018, an estimated $11.4M increase.
  • Sectoral Asset Management's biggest Q2 2018 reduction was Celgene Corp, cutting an estimated $23.5M.
  • Sectoral Asset Management fully exited Acadia Pharmaceuticals in Q2 2018, selling an estimated $17.6M.
  • Sectoral Asset Management's ten largest holdings make up 39% of its $894M portfolio in Q2 2018.
  • Sectoral Asset Management opened 8 new positions and closed 9 in Q2 2018.
  • Sectoral Asset Management's portfolio value fell 1.9% quarter-over-quarter to $894M.

Based on Sectoral Asset Management's 13F filing for Q2 2018, filed 13 Aug 2018.